Market Overview

UPDATE: Piper Jaffray Upgrades Aeropostale to Overweight; Pricing Suggests Margin Recovery

Share:
Related ARO
Mid-Afternoon Market Update: Dow Falls 100 Points; Sarepta Therapeutics Shares Drop Following Release of FDA Briefing Documents on Eteplirsen
Aeropostale's Stock Plunges Following Bloomberg Report Company Is Preparing To Declare Bankruptcy

Piper Jaffray raised its rating on Aeropostale (NYSE: ARO) from Neutral to Overweight and increased its price target from $20 to $24 a share.

Piper Jaffray commented, "We believe the consistency in the pricing delta between AE / Hollister and Aero over the first two weeks of BTS, trending in the mid-50% range, will support market share recapture and margin recovery at a faster pace than previously modeled. We are raising our estimates, taking an above-consensus stance for FY13 at $1.32 and FY14 at $1.60. Beyond BTS, we are intrigued by the growth prospects for P.S. by Aeropostale, acknowledging a favorable youth demographic tailwind and potential business model leverage."

Aeropostale closed at $19.67 on Friday.

Latest Ratings for ARO

DateFirmActionFromTo
Aug 2015Wolfe ResearchInitiates Coverage onPeer Perform
Jul 2015UBSDowngradesNeutralSell
May 2015Stephens & Co.MaintainsEqual-weight

View More Analyst Ratings for ARO
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (ARO)

View Comments and Join the Discussion!